Blast Crisis
4 clinical trials · Condition
| Record | Firm | Date |
|---|---|---|
| Phase 1 Study of TG02 Citrate in Patients With Advanced Hematological Malignancies (NCT01204164) | Tragara Pharmaceuticals, Inc. | 2010-08-01 |
| Dasatinib (BMS-354825) in Subjects With Myeloid Blast Phase Chronic Myeloid Leukemia Resistant to or Intolerant of Imatinib Mesylate (NCT00101816) | Bristol-Myers Squibb | 2004-12-01 |
| Study of Farnesyl Protein Transferase Inhibitor (FPTI) in Patients With Leukemia (Study P00701) (NCT00034684) | Merck Sharp & Dohme LLC | 2001-07-01 |
Track Blast Crisis automatically
Every clearance here is in the API, with alerts when new ones post.